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Abstract Evidence-based approaches to policy-making are growing in popularity.
A generally embraced view is that with the appropriate evidence at hand, decision
and policy making will be optimal, legitimate and publicly accountable. In practice,
however, evidence-based policy making is constrained by a variety of problems of
evidence. Some of these problems will be explored in this article, in the context of
the debates on evidence from which they originate. It is argued that the source
of much disagreement might be a failure to addressing crucial philosophical
assumptions that inform, often silently, these debates. Three controversial questions
will be raised which appear central to some of the challenges faced by evidence-
based policy making: firstly, how do certain types of facts candidate themselves as
evidence; secondly, how do we decide what evidence we have, and how much of it;
and thirdly, can we combine evidence. In addressing these questions it will be
shown how a philosophically informed debate might prove instrumental in clari-
fying and settling practical difficulties.
Keywords Evidence  Policy-making  Facts  Practical objectivity 
Transparency
1 Introduction
Nowadays there is an increasing political emphasis about using evidence—in
particular, scientific evidence—to inform and develop policy in a wide range of
areas: health and social care, housing, transport, education, criminal justice, etc. As
Cartwright (2007a, b) well explores, governments are more and more willing
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to fund evidence-based approaches to policy-making; and government funding is
increasingly tied to the demand for evidence.
In the United Kingdom evidence-based policy has become the way ahead for
developing social programmes ever since the election of the Labour Government in
1997.1 In June 2000, the UK Treasury established the Evidence-Based Policy Fund
with a budget of £4 million over 2 years.
An example of this commitment is the so called ‘‘Sure Start’’ programme, started
in 2001 with the aim of breaking the cycle of poverty by providing children and
families with childcare, health, and educational support. This programme was
conceived and carried out in evidence-based style: extensive reviews of research
findings were compiled to show what approaches and early interventions are most
likely to work. Also its execution and continuing evaluation and refinement have
been evidence-based.2
We find another example of governmental commitment to evidence-based policy
making in the decision of the UK Parliament’s Select Committee on Science and
Technology to establish an inquiry into ‘‘Scientific Advice, Risk and Evidence: How
Government Handles Them’’ (November 2005). The inquiry focused on ‘‘the
mechanisms in place for the use of scientific advice (including the social sciences)
and the way in which the guidelines governing the use of such advice is being
applied in practice across Government’’. Its aim was also specifically to ‘‘test the
extent to which policies are ‘‘evidence-based’’’’(Scientific advice… 2006).
The evidence-based movement has also gained importance in Europe. In its 2001
White Paper on governance, the European Union acknowledged that:
Scientific and other experts play an increasingly significant role in preparing
and monitoring decisions. From human and animal health to social legislation,
the Institutions rely on specialist expertise to anticipate and identify the nature
of the problems and uncertainties that the Union faces, to take decisions and to
ensure that risks can be explained clearly and simply to the public.
(Commission of the European Communities 2001)
So it seems that the generally embraced view is that with the appropriate
evidence at hand, decision and policy making will be optimal, legitimate and
publicly accountable; that with the appropriate evidence, bias and arbitrary
decisions will be eliminated, or at least monitored and kept at bay.
Unfortunately, we know that things are far from being so straightforward and
clear cut in practice. Evidence-based policy making is constrained by a variety of
problems of evidence. The evidence may be uncertain (e.g. the long term impacts of
radiation from mobile phones); it may be subject to differing interpretations (e.g.
global warming); it may be misunderstood (e.g. misunderstandings of conditional
probabilistic diagnostics in medicine); or it may be challenged by competing values
1 A clear sign of this commitment can be found in the 1999 White Paper Modernising Government,
which called for the ‘‘better use of evidence and research in policy making and better focus on policies
that will deliver long term goals’’ and stipulates evidence as a key principle for policy making. See
Cabinet Office (1999), p. 16.
2 For example, proposals to expand the Sure Start programme led to a £16 million research project which
intended to establish whether the programme was actually achieving results. See Hunter (2003).
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(e.g. GM foods). Given these varying contexts in which evidence is problematic,
evidence-based policy making might come to look more like an unduly optimistic
generalization, if not a rhetorical statement, than a de facto description of a process
of governance.
In an attempt to handle this complex host of problems a considerable amount of
work has been put onto how to regulate the use of evidence. New institutional rules,
structures and guidelines have been suggested with this aim in mind.
For example, the Campbell Collaboration is an ‘‘independent, international, non-
profit organization that strives to provide decision-makers with evidence-based
information to empower them to make well-informed decisions about the effects
of interventions in the social, behavioural and educational arenas’’ (www.
campbellcollaboration.org).
It is modelled on the Cochrane Collaboration for medical research and it plays a
key role in the evidence-based practice (EBP) movement, trying to promote a
culture which values empirical findings and rigorous research based on them.
However, when it comes to advice on what research can be accepted for inclusion in
systematic reviews, and on what methodologies are the best deliverers of evidence
(and in what sense of ‘‘the best’’), the debates turn controversial.
Arguably, the source of much disagreement often is a failure to addressing
crucial philosophical assumptions that inform, often silently, these debates.
Nonetheless, a current view among practitioners is that philosophical awareness
has little bearing on how to handle real difficulties in practice.
In what follows I raise three questions which seem to me central to some of the
challenges faced by evidence-based policy making, and hopefully will show how a
philosophically informed debate might prove instrumental in clarifying and settling
practical difficulties.
In the process of showing this, the choice of what type of philosophical analysis
is to be used to reflect on the practical issues thrown up by policy-making will have
to be assessed. In particular, the philosophical analysis will have to undertake the
arduous task of proving itself to be sensitive to the type of problems it is to tackle.
Making philosophy and societal issues interact is not a simple, nor an automatic
process. An ‘‘applied philosophy of science’’ becomes then a new area of research
worth its challenges. In other words, if carried out with due care and open-
mindedness, an interaction between philosophy of science and societal issues will
produce mutual readjustments in perspective and interpretation which will hopefully
prove beneficial to both fields.
2 How Do Certain Types of Facts Candidate Themselves as Evidence?
The whole point of basing a policy on reliable evidence is to eliminate bias and
decisions taken on arbitrary grounds. Conceiving policies on the basis of good, solid
empirical findings seems just the way to achieve this.
What makes evidence solid? Even before that, what makes ‘‘evidence’’?
Traditional philosophical theories do not seem to be of great help here.
Cartwright, in the paper already referred to, rightly points this out by reference to
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probabilistic theories of evidence. These theories focus on the probabilistic relations
between evidence and hypothesis. For example many accounts demand that, for e
to be evidence for a hypothesis h, e should increase the probability of h:
P(h/e) [ P(h/:e).
Cartwright writes:
These accounts are good at ensuring that evidence, as they define it, does what it
is supposed to do, i.e. providing grounds for belief in h. But in policy making the
question of evidence is not quite the same. (Cartwright 2007a, b, p. 4)
Probabilistic theories of evidence strive to attach degrees of certainty to a piece
of evidence. However, this is only half of the story. In policy making we already
know that evidence for a policy conclusion should make the conclusion probable. In
practice, if evidence is to be used in order to make a policy conclusion probable, we
need to figure out, for example, what kinds of facts make this conclusion probable
and under what circumstances; or what makes them relevant to the conclusion they
are meant to support. Besides, and as we will see later, we also want to be able to be
open to new evidence, evidence which—though not conclusive or highly certain at a
particular time—might indeed ‘‘vouch’’ in favour of a certain conclusion.
Therefore, Cartwright concludes, for purposes of policy deliberation, definitions
of ‘‘evidence’’ in terms of probabilities, seem to put the cart before the horse.
So our question still stands: what makes ‘‘evidence’’?
Practical guidelines are formulated, purportedly, to answer precisely this
question. Nonetheless we encounter problems here too.
For example, there is a widespread recommendation in policy practice to evaluate
evidence according to ‘‘evidence-ranking schemes’’.3
The idea behind these schemes is that a fixed rank can be given to kinds of
evidence, and then depending on how the kinds are ranked, they are positioned in a
hierarchy within the scheme. The scheme then ‘‘adjudicates’’ evidence from the
very best to the second best, all the way down to the worst (less/least reliable).
By glancing through these hierarchical schemes, one cannot fail noticing that best
evidence is almost always associated with one particular type of methodology: well
conducted randomized control trials (RCTs).4
A typical example of a ranking scheme is as follows (SIGN 2004):
(1) ?? RCTs
(2) ?? case–control or cohort studies
(3) non analytic studies, e.g. case reports, case series
(4) expert opinion
3 Examples of these ‘‘ranking schemes’’ can be found in SIGN (2004); or the Oxford Centre for
Evidence-based Medicine Levels of Evidence (2007).
4 A randomized controlled trial (RCT) is an experiment in which investigators randomly assign eligible
subjects (or other units of study, e.g. classrooms, clinics, playgrounds) into groups. Each of the groups
receives or does not receive one or more interventions (e.g. a particular treatment). Then the results are
compared, and if the observed outcome is statistically significant, then it can be concluded that it has
indeed been caused by the experimenters’ manipulation, i.e. there is a high probability that the
intervention actually works. Blind procedures (single, double, triple to even quadruple) are used to control
bias.
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What we evince in terms of recommendation from these schemes seems to be the
following:
(1) evidence is whatever appears on the list;
(2) the strength of evidence depends on the place a method has on the list;
(3) the recommended form of evidence amounts to something like ‘‘go with
whatever appears at the top of the list’’ (i.e. well conducted RCTs).
There are several reasons why RCTs are normally chosen as best evidence
providers. One of them is that they have inbuilt assumptions which ensure the
results (their results can be directly deduced from the evidence provided). Another
is that they calculate evidence in terms of probability, so the higher the probability,
the better the evidence (and given that all concepts are operationalised, bias is under
strict check).
However, Cartwright makes us aware that accepting RTCs as best evidence
entails that we already have a theory of what evidence consists of, namely what
RCTs provide (a further case of putting the cart before the horse). From here we
then rightly feel entitled to eliminate all the rest. Nothing else quite matches with
the ideal of evidence provided by RCTs, therefore it may simply be discarded.
At this point, at least two related orders of problem seem to arise:
Firstly, if we accept that RCTs are best evidence, this means that they can be
applied universally and that the results they deliver are always the best results in
terms of evidence, independently of where we use them. However, how do we know
that RCTs are the best providers of evidence in any and every context?
Indeed, a well conducted RCT might be effective in one context but not
necessarily in another.
Secondly, there are contexts in which other forms of evidence might be more
effective in reaching certain conclusions; or the questions we are pursuing might not
enter in the range of questions included in a RCT; etc. Why should we simply ignore
all the evidence which comes from other sources?
By focusing on the quality of evidence (the better the evidence, i.e. the more
probable, the more certain the results) it seems that two crucial related issues (at
least in the context of policy-making) are neglected: the relevance of evidence (i.e.
how to decide when a high quality result bears on the acceptability of a policy
proposal, but also how other, though less certain, results might bear on it), and its
effectiveness (i.e. how to decide that what is efficacious in an ‘‘ideal’’ or ‘‘closed’’
setting, e.g. an RCT, will also be so in a practical, ‘‘open’’ one, e.g. a school, or a
family).
The social world is complex, and motley: why should we expect that a ‘‘one-size-
fits-all’’ strategy can handle this complexity? Or that whatever might seem to work
best in one situation should be the best in principle?
An example might help illustrating this.
In 1995 the Dutch Minister of Health authorised a randomised clinical trial of
heroin-maintenance for heavy users. At the time there were 24,000 heroin users in
the Netherlands, and about half of them participated in some or other methadone
programme. However, the great majority of them did not improve. The aim of the
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RCT was to find out whether additional provision of heroin would improve the
quality of life (medical, psychological, social) of these drug users.
After years of fierce debates and opposition, the minister and her scientific
advisers, arguing that RCT was the ‘‘truly scientific’’ approach which would lead to
unambiguous, ‘‘objective’’, evidence-based results, won the battle and the exper-
iment commenced.
Trudy Dehue studied the experiment, and followed it up between 1997 and 2001
to comment on its progress and results (Dehue 2002). Her analysis of the case is
detailed and rich, but a few issues can be quickly and relevantly recalled to illustrate
the points I am raising in this section.
The first aspect she delves into concerns the composition of the control groups for
the experiment. The expectation was that the simple offer of free drugs would be
enough to attract participants in large numbers. On the contrary, it was difficult from
the start to meet even the minimum number required to make up the groups (and in
fact the numbers were reconsidered when it became clear that the initial estimates
were not going to be met). What the experiment did not take into account was that
addiction is not just a physical affair. It is also a way of life, ‘‘part of an alternative
culture, which is at least as important as the substance itself’’ (ib., p. 90).
In order to acquire their daily dose, the participants in the experiment had to go to
a maintenance station three times per day, seven days a week, pass a metal detector
door, be watched all the time (to avoid smuggling), be randomly selected for urine
tests, undergo a thorough medical and psychological test every month… Heroin
addicts started complaining that government’s heroin ‘‘tasted differently’’, that there
was probably something wrong with it, that it tasted like ‘‘nasty rotgut’’. No wonder,
Dehue remarks:
Which wine buff would enjoy the finest glass if it were handed out through a
window in a maintenance station? […] Few people take pleasure in a free
gourmet dinner followed by intrusive examinations and interviews urging
them to break with the gastronomic community. (ibidem)
Heroin on prescription is nothing like free heroin: its recipients had to pay a
price, by adhering to a regime of drug-taking which was totally foreign to them.
A second matter raised by Dehue concerns the use of classifications in the
experiment. Drug users were defined as ‘‘patients’’, and this, we are made to realize,
is not without its consequences. In particular, it partly explains the reason for the
difficulty in recruiting participants in the experiment. It has been argued—for
example by Nora Storm, spokeswoman of the Rotterdam Junkie Union—that only
those capable and willing to adapt to the rules set out by the experiment in the end
took part in it; and many left before it ended. Self-selecting strategies emerged
within the selected groups, which cast doubt on the purported effectiveness of the
results.
Interestingly for us, Dehue does not take issue with whether the methodology of
RCT in the case of the Dutch heroin experiment was strictly adhered to, or whether
infringements in the protocols of experimental research were responsible for its
shortcomings. ‘‘Even in perfect RCTs—she argues—in which each collaborator or
participant fully keeps to the experimental protocol, the results cannot represent
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reality as it is’’.5 We could rephrase this by saying that the ‘‘reality’’ portrayed by
the experiment goes hand in hand with the methodological constraints set out by the
experiment itself. So the experiment does not provide ‘‘objective evidence’’ in the
sense argued for by both Dutch scientists and politicians, that is evidence which is
impartial, unambiguous and credible. What the experiment guarantees is that, given
the constraints and assumptions of the RCT set up for this particular case, results
follow according to the controlled style of the experiment (what Cartwright would
call a ‘‘clinched’’ methodology). But what control do we have on those very
constraints and assumptions?
This illustrates our first problem above: there is no reason in principle why RCTs
are the best providers of evidence in any and every context—let alone the only
providers. The American National Institute of Drug Abuse published a volume on
‘‘Qualitative Methods in Drug Abuse and HIV Research’’ where it is pointed out
how only few social scientists pay enough methodological attention to the complex
types of behaviour (individual as well as social) related to drug use and HIV
infection (ib., p. 91). It is then recommended that an ad hoc ethnography could be
used to develop such a methodology. This would entail studying natural groups
rather than artificial ones, or interpreting drug-culture by participating in it rather
than observing, testing and recording it. This is not to be taken as a suggestion that
ethnography is more objective than RCTs in analysing the reality of drug abuse
(ethnographic methods have indeed their own problems and riddles). It should rather
lead us to acknowledge on one side, that social phenomena can (and ought to) be
approached by different methods, each of which displays different degrees of
effectiveness; and on the other, that ignoring evidence coming from different
sources might be not only wasteful, but harmful.6
Of course the problem then becomes that of how to compare and combine the
different types of evidence, as I will discuss in the final section. Before coming to
this, a preliminary and equally important issue ought to be addressed.
3 How Do We Decide What Evidence We Have, and How Much of It?
The way in which scientific information/data are presented and communicated bears
on how those data might be used as crucial or relevant or effective evidence for or
against certain conclusions. Gerd Gigerenzer in his Reckoning with Risk discusses
some interesting examples.7
In 1995 a ‘‘contraceptive pill scare’’ occurred in Britain. According to the official
statement,
5 Ib., p. 86. Dehue claims that the Dutch experiment was indeed designed in the respect of the highest
standards.
6 On this more general issue see also Cartwright (2007a, b), Seckinelgin (2007).
7 Gigerenzer (2002). Gigerenzer’s examples are discussed in the context of dealing with risk and the
uncertainties of daily life. Nonetheless the way they are set out become instructive vis a vis some of the
features we are discussing here concerning evidence.
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the contraceptive pill is associated with a 100% increase in the risk of
thromboembolism.
This can indeed be taken as strong evidence against its use. However, Gigerenzer
asks, how is such a risk calculated? The figure in the statement is one of what is
called ‘‘relative risk’’, that is a measure of the efficacy of a treatment in terms of the
relative number of people saved.
This though is not the only way to represent risk. A different calculation takes the
form of ‘‘absolute risk’’, by measuring the efficacy of a treatment in terms of the
absolute number of people saved.
Gigerenzer shows that the statement reporting the figure of 100% increase in risk
of thromboembolism can be restated in terms of absolute risk as follows:
the risk of thromboembolism increases about 1 to 2 in 14,000 women.
Indeed, the new figure makes us look at the official statement with different eyes.
Different ways of calculating the risk associated with mammography screening
offer similar results, and prompt similar reflections.
There are here at least three ways of presenting the benefits of screening:
(a) relative risk reduction: mammography screening reduces risk of dying by
25%;
(b) absolute risk reduction: mammography screening reduces the number of
women who die of breast cancer by 1 out of 1,000 (0.1%);
(c) number of women needed to be screened: in order to prevent 1 death, the
number of women who need to be screened for 10 years is 1,000.8
Very rarely, Gigerenzer argues, these types of risk are presented according to the
figures provided by absolute-risk calculations. Why? The general public is normally
impressed by large figures, the figures which hit the headlines—even though going
along with them might create extensive social and individual damage (regarding the
two cases just analysed: an increase in unwanted pregnancies and abortions; or
physical and psychological consequences for about a million women per year in the
US which get false positives as a result of mammography screening).
This, as I take it, is not to argue against screening programmes, or in favour of a
reckless use or underuse of the contraceptive pill, but to make a point about the fact
that relying on scientific evidence should be approached with a rather nuanced
attitude. There are different techniques to calculate, and then to present,
communicate and use, the evidence relevant to making certain decisions (or, in
Gigerenzer’s context, of reckoning with certain risks), to the point that ‘‘favourable’’
or strong evidence might appear not as favourable and strong by using, say, a
different method of calculation. Awareness of the pros and cons of these methods
should be publicly accessible and criteria for making informed decisions should be
made part of the general debate.
8 There is also a fourth way to present the benefit: ‘‘increase in life expectancy’’ (women between 50 and
69 who participate in screening increase their life expectancy by an average of 12 days). See Gigerenzer
(2002, p. 59).
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4 Can We Combine Evidence?
As we have seen, evidence can come from different sources, be provided by
different methodologies, and be communicated by different means. If we believe
that such a variety should not be ignored, how can we compare and combine
evidence in view of assessing (often ‘‘on balance’’) the so-called ‘‘strength of
evidence’’—or, at a more basic level, in view of acquiring at least sufficient and yet
relevant evidential support?
Two examples will allow us to reflect on this important issue, and give us some
clues as to how to address it.
The first comes from the legal field.
DNA sampling, when first introduced as forensic evidence for the identification
of the culprit of a crime, was treated by the courts of law as a conclusive proof of
identity. It is well known that it is impossible for two individuals to have exactly the
same genome (with the exception of clones and absolutely identical siblings).
However, in reality things are not so clear cut. Forensic scientists could never have
the time and large resources needed to produce a full genetic map from a DNA
sample. Instead they use, by routine, a limited number of markers, and at this lower-
scale level it is no longer impossible that the same DNA sample could be shared by
distinct individuals. However, if this is the case, a DNA match (and its impeccable
scientific credentials) cannot count any longer as a ‘‘proof’’ of identity.
Does this then mean that DNA evidence should be inadmissible (due to its
unreliability) evidence in the courts of law? Statistical calculation comes to the
rescue: we are able to calculate the strength of DNA matches in terms of
probabilities, and assess rather accurately how much the evidence speaks in favour
or against a person having committed a certain criminal offence. Nonetheless, in the
course of a trial different bits of evidence come into play which, because of their
nature and origin, might not so obviously be treated statistically. How can science-
informed evidence be compared with and weighed against other non-scientific
evidence, in view of reaching a balanced, and as far as possible complete and
‘‘objective’’ assessment of the case under scrutiny?
An interesting case illustrates how to handle these questions.9 In January 1995
Denis John Adams, who lived in an area where a crime of rape was committed, was
accused and tried for sexual assault on the evidence of a DNA match between
Adams and a sample of semen extracted from the victim. No other incriminating
evidence was put forward by the prosecution. The defence presented two bits of
counter-evidence: the victim did not identify Adams as her assailant, and Adams’s
girlfriend testified that they were together at the time when the crime was
committed.
Figures attached to the DNA match probability went from 1 in 200 million
(favoured by the prosecution) to 1 in 2 million (not excluded by the defence). Still,
even accepting the 1 in 2 million scenario, the likelihood ratio:
9 For a discussion of this case I refer to Dawid (2008) and Lynch and McNally (2003).
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The probability of obtaining the DNA match; if Adams is guilty
The probability of obtaining the DNA match; if Adams is not guilty
is 2 million, that is very strong evidence of guilt.
However, the problem in the Adams case is that all the other evidence submitted
to the court was evidence against guilt. Should all this extra evidence be ignored,
given that the DNA evidence appears to be so overwhelming? Were we to put the
DNA evidence in a ranking scheme, it would position itself at the top of the
hierarchy by being associated with seemingly undisputable (i.e. quantitatively
measured) credentials, unlike other types of evidence, engulfed in highly disputable
questions (how do we know that Adams’ girlfriend is not lying? Under what and
how many circumstances is a victim unable to recognize his/her assailant? etc.). We
might then be tempted to follow the recommendation: ‘‘stick with the best’’.
However, a jury, in order to be fair, cannot afford following such a
recommendation. But how can it make all evidence bear on the case?
The clever move of the defence lawyer was to try also to put the evidence in
favour of innocence in terms of probabilities, with a resulting overall likelihood
ratio of 1 in 18 in favour of guilt. If there was cause for reasonable doubt before the
defence evidence, after it there can be absolutely no case for conviction.10
Dawid’s conclusion is that without the principles of probability theory for
guidance, forensic scientists would be very unclear as to how to interpret evidence.
However, even setting aside the thorny issue of how scientific and statistical
evidence can be competently handled by a lay jury,11 we should indeed question.
• to what extent can/should non scientific evidence be put in scientific form (e.g.
statistical form);
• whether the aim of combining scientific and non scientific evidence can only be
pursued by ‘‘translating’’ the latter in the language of the former.
Even only a sketchy answer to both of these queries should take into account
firstly, that not any sort of evidence can indeed be translated into scientific or formal
terms without any loss in meaning or relevance. What about, for example, the
demeanour of witnesses, or the credibility of testimony? As has been pointed out:
‘‘They involve elements of trust, which are fallible, difficult to justify, and
impossible to quantify’’. Besides, the language of quantification, which has become
the emblem of late-modern society, seems not only to carry with it an ‘‘intimidating
sense of objectivity’’, but also to project a ‘‘misleading or potentially confusing
appearance of objectivity when applied to ‘‘non scientific evidence’’’’.12 Secondly,
even assuming that all the available evidence can be made comparable by adopting
10 By means of Bayesian calculus, Phil Dawid shows us that what we get at the very end is that there are
five chances of guilt in a total of 14, which means in terms of guilt probability 5/14 = 35%.
11 It is interesting to note that the jury, despite struggling with the complex statistical argument which
was presented to them, and accepted without objection at trial, reached a verdict of guilt. Clearly, the
immense odds of the DNA evidence had an overwhelming effect on the jurors’ assessment of the
evidence.
12 See Lynch and McNally (2003, p. 96). On the use and role of numbers in modern society see Hacking
(1975), Porter (1995) and Gigerenzer et al. (1989).
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a common language of communication, the combination of various bits of evidence
in view of reaching an objective verdict or judgment is neither automatic nor
straightforward, and is deeply dependent on the method/s of combination adopted—
as we learn from a second case study.
The field of this second case is vaccine research.
A storm of controversy in England arose in 1998 around a paper which claimed
evidence in favour of the existence of some causal link between MMR vaccine
(Measles, Mumps and Rubella) and child autism. The paper, written by Dr. Simon
Wakefield (accredited doctor in the field), was published in The Lancet (prestigious
medical journal) (Wakefield et al. 1998) in a receptive milieu of public
apprehension towards the use of vaccines, especially on children. The result was
a dramatic decrease in children vaccination, with a consequent decrease in children
immunization.
Due to public and media pressure, Wakefield’s paper was subjected to accurate
examination. A whole host of ethical and procedural violations were raised. For
example, a problem of sample bias was pointed out, i.e. the subjects involved in the
study comprised a subset of children whose parents were already aware of
Wakefield’s interests. The findings quoted as evidence had not been reproduced to
such an extent which could have been convincing for the experts. The uncertainty of
the laboratory evidence used to support the causal claim also raised concern, in
particular since evidence against the claim was supported by epidemiological
studies. In the end, all this led to a retraction. However, and interestingly for us,
none of the objections put forward as ‘‘evidence to the contrary’’ provided on its
own the crucial clue to the resolution of the controversy.
The question then becomes: how is it possible in situations as controversial as
this to reach a conclusion which is objective—that is, able to take into account the
different types of evidence and combine them is such a way that a well balanced
judgment is ultimately reached?
A good starting point for answering this question is to establish what ‘‘objective’’
entails in practical domains. There are three features which are normally referred to
in talks of objectivity. Rather than positive features, they are features which point
out what ought to be excluded from objective assessment.13
The first is the feature that excludes subjective or individual opinion from the
process of assessment. Transparency is by routine invoked in the evaluation of the
evidential findings claimed to bear on a controversial case. To be transparent entails
making the conditions of evaluation not only explicit, but more specifically
independent of subjective judgement. Often this is said to be achievable by relying
on quantitative methods, rather than qualitative (see Suter 1993). The assumption is
that qualitative methods are inherently subjective, in a way that quantitative ones
are not.
A second feature which seems to be associated with objectivity is the exclusion
of uncertainty. Diversity of opinion, for example, might be a source of uncertainty
in judgment. Therefore, it might be claimed, it needs to be reduced in favour of
consensus.
13 In what follows I make reference to the three features of objectivity as discussed in Martin (2006).
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A third feature importantly associated with objectivity is the exclusion of values,
ideologies and political interference. Such an exclusion would achieve that ideal of
objectivity which Daston and Galison, in a different context, have defined in terms
of ‘‘mechanical’’,14 that is that type of objectivity entirely based on methods and
instruments which reduce human intervention close to zero.
Interestingly, all three features of exclusion seem to portray objectivity more as
an idealized concept, as it would have only few chances to succeed in practice.
As to the first feature, it is not necessarily the case that quantification is ipso facto
a guarantee for objectivity. A quantitative interpretation of data can be flawed, it
could rely on bad methods, and arguably it is not necessarily the case that such an
interpretation does not entail judgements of any sort (let alone value judgments).
Besides, as pointed out in relation to the Adams case above, there might be features
or aspects which might be untranslatable in quantitative terms, or at least at the cost
of loosing specificity.
As to the second feature, it is not necessarily the case that if the findings are
uncertain then because of this they are necessarily negligible. Cartwright for
example makes a useful distinction between evidence which is conclusive, as it is
provided by methods which ‘‘clinch’’ their conclusions, and evidence which is not
conclusive, as it is offered by methods which only ‘‘vouch’’ for their conclusions.
Examples of the latter include ethnographic methods, qualitative comparative
analysis and the hypothetico-deductive method (which, incidentally, is at the heart
of successful physics). Clinching methods (such as RCTs) are indeed appealing,
though their range of application is quite narrow, and they leave us with the problem
of how to decide what to retain and what to discard of all the non conclusive
evidence provided by non clinchers (Cartwright 1999, 2007a, b).
As to the third feature, again it seems that it is not necessarily the case that if
findings are value-laden then they are necessarily biased. Not all values are alike,
and not all values constitute bias. Values might inform and solicit good science (as
for example in the case of climate science) to the point that the naturalistic fallacy
might arguably cease to be a fallacy. A value-sensitive science might be a better
option, besides being a more realistic one, than a value-free one.
All in all, what all these features of exclusion fail to show us is how objectivity
should itself be looked at as a practical achievement, and as the result of practical
procedures, which take necessarily on board the questions, the methodological
assumptions and the empirical findings made available by a context of investigation.15
We can now go back to our question above: how is it possible in situations as
controversial as the MMR vaccine to reach a conclusion which is objective—at least
‘‘on balance’’? A practical concept of objectivity tells us that the way ahead entails
combination. To be objective is not to exclude aspects from the final assessment,
should they appear too subjective, too uncertain, too value laden. To be objective is
to make use of the evidence available, in a fruitful combinatorial framework.16 An
14 Daston and Galison (1992, 2007). For some, the way to achieve this task consists of a proper use of
statistical analysis. See for e.g. Mayo (1988).
15 On how to describe a model of objectivity with these characteristics see my (2003).
16 Haack (2003) uses the image of a crossword puzzle.
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objective conclusion is a conclusion which takes into account different types and
sources of evidence (for example, in the vaccine case, epidemiological, laboratory,
clinical). Such a combination is not achieved at random. It must rather rely on a
variety of methods of combination. A mixture of practical strategies and methods
are already in place, for example:
(1) leave it to the experts—where somehow the authority of individual scientists
comes to play a prominent role, and is taken almost for granted;
(2) simply pool all the evidence together—whereby the experts will have a
‘‘reference point’’ that summarises the state of current research;
(3) literature review—which offer surveys of relevant studies and then draws a
conclusion about what these studies have in common, or what they point out.17
More sophisticated methods for combining evidence might include meta-analysis
(statistical combination of the results of several studies); or Bayesian nets (complex
diagrams that organize a body of knowledge by mapping out cause-and-effect
relationships among key variables and by encoding them with numbers that
represent the extent to which one variable is likely to affect another); or the already
discussed ranking schemes (although these do not seem so much to ‘‘combine’’
evidence, but rather to select certain types of evidence to the exclusion of others).
Each of these methods has limitations, and poses further methodological
challenges, as Martin points out in his paper. For example, the ‘‘leave it to the
expert’’ strategy immediately raises a question as to who the experts are, and what
type of expertise is invoked (as well as how inclusive or exclusive the expertise in
question is). Or, in the case of ‘‘pool all the evidence together’’, we might well
concede that data can be pooled into a sort of ‘‘library of evidence’’,18 but the
evidence these data elicits is not the sort of thing which can easily be aggregated in
view of reaching a univocal conclusion. Besides, we should not expect that these
methods miraculously combine all the evidence needed. Finally, and most
importantly, any methodological standard fixed apriori puts serious restrictions on
our need to respond to new evidence. If we fix standards in advance, and we only
allow ourselves to proceed according to them, we might find it hard even to
recognize that new evidence has been achieved, let alone put forward.
Nonetheless, all these difficulties should not deter us from pursuing the goal of
combination, if one of the aims of policy making is accountability, that is favouring
procedures which are on one side both accessible and trustworthy, and on the other
successful in achieving objective outputs.
5 Conclusion
Practical objectivity is then a form of objectivity ‘‘on balance’’. It is the only kind of
objectivity which fits the domain of policy making, a domain where it is never the
case that just one piece of evidence speaks in favour or against a hypothesis.
17 These are listed in Martin (2006).
18 The expression is Thomas Jefferson’s from Jefferson (2003); quoted by Martin (2008, p. 13).
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Evidence for policy always includes conflicting claims, and these claims need then
be evaluated and combined in view of reaching a policy decision. It often also
includes uncertain claims, which ought not to be discarded simply because of their
uncertainty. Uncertain evidence is not necessarily bad, or false evidence; and it is
often better that no evidence at all.19
The central question then becomes how to arrive at rational, effective and
objective decisions when different relevant (or candidate) voices speak differently
for different outcomes, or when it is not clear what specific result a voice speaks for.
Though such a question is at the core of evidence-based policy making, it might not
find adequate answers by relying on policy makers alone; nor on the experts called
in to provide the required findings to informing those voices.
Confronting this question firstly entails critical awareness of the principles, the
standards, the methods and the epistemological justifications of the methods used to
reach certain conclusions. Secondly, making use of evidence in domains other than
the scientific ones (e.g. the practical contexts of policy making) does not only raise
an issue over the reliability of that very evidence (how scientifically ‘‘sound’’ it is).
Most importantly, it raises an issue over the ‘‘applicability’’ of that evidence, where
the contexts of application have features and causal powers of their own, able to
affect the strength, the legitimacy and the relevance of the scientific findings
themselves.
Both fields (meta-methodological awareness and critical applicability) can, I
believe, be conquered and mastered by philosophical expertise, for the benefit of all
players (including non philosophers). Of course this type of philosophy in practice
should be up to the challenges and the sui generis problems coming from practice
itself.
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